syringic acid has been researched along with Obesity in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Homma, Y; Iwamoto, K; Kawaguchi, N; Moriyama, T; Shirasaka, N; Suzuki, T; Tanaka, T; Wada, M; Yano, E | 1 |
| Achar, RR; Babakr, AT; Maradesha, T; Martiz, RM; Patil, SM; Prasad, A; Ramu, R; Silina, E; Stupin, V | 1 |
| Choi, RY; Ham, JR; Lee, HI; Lee, MK; Seo, KI; Sim, MO | 1 |
3 other study(ies) available for syringic acid and Obesity
| Article | Year |
|---|---|
Dietary syringic acid reduces fat mass in an ovariectomy-induced mouse model of obesity.
Topics: Animals; Body Weight; Diabetes Mellitus, Type 2; Diet, High-Fat; Female; Gallic Acid; Humans; Mice; Obesity; Ovariectomy | 2021 |
Integrated network pharmacology and molecular modeling approach for the discovery of novel potential MAPK3 inhibitors from whole green jackfruit flour targeting obesity-linked diabetes mellitus.
Topics: Artocarpus; Diabetes Mellitus; Flour; Methanol; Mitogen-Activated Protein Kinase 3; Molecular Docking Simulation; Molecular Dynamics Simulation; Network Pharmacology; Obesity; Protein Kinase Inhibitors | 2023 |
Anti-steatotic and anti-inflammatory roles of syringic acid in high-fat diet-induced obese mice.
Topics: Animals; Anti-Inflammatory Agents; Diet, High-Fat; Fatty Liver; Gallic Acid; Humans; Insulin; Interleukin-6; Leptin; Liver; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Obesity; PPAR alpha; Sterol Regulatory Element Binding Protein 1; Triglycerides | 2016 |